The introduction of heat-not-burn cigarette substitutes in
Japan has led to a precipitous reduction in cigarette consumption.
Tobacco industry analyst Michael Livery of Piper Jaffray
recently issued a report on the Japanese market, citing 2017 sales data. The
chart at left suggests that Philip Morris International’s IQOS heat sticks (green)
and BAT’s Glo products (blue) caused a 13% decline in cigarette consumption for
the year. Livery deliberately
underestimated the number of heat sticks sold because of evidence that up “to
20% (4th Quarter 2017) of iQOS HeatStick volumes…is getting re-sold
in China, Thailand, and Hong Kong, and likely other parts of Asia.”
I suggested (here)
that a similar result could be possible in the U.S., if the FDA grants marketing
approval for such products. The agency, however, appears to be in no rush to make
a decision.
Philip Morris submitted a premarket tobacco application
(PMTA) to the FDA on March 31, 2017; it has been pending ever since.
According to the FDA (here), if a
PMTA is accepted and found to be complete, the agency will file it and begin
substantive review. “After completing
its review, FDA intends to issue an order within
180 days after receipt of the
Premarket Tobacco Application that the new product may or may not be introduced
or delivered for introduction to consumers.” (emphasis added)
The FDA took eight months to grant Swedish Match a PMTA for eight
snus products in 2015 (here). This week marks the twelfth month of FDA
consideration of the IQOS PMTA submitted March 31, 2017.
It is often said that regulation is a slow, deliberate
process. But in this instance the FDA is
in apparent violation of its own procedural guidelines. The FDA simply slow walks any decision on
safer options for smokers: it took 2.5 years (here)
and 4 years (here)
to reject requests to correct inaccurate smokeless tobacco warnings. All of these are examples of regulatory
purgatory that I warned about six years ago (here).
Our country’s smokers and their loved ones deserve better.
No comments:
Post a Comment